Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONDK
3101
DELISTED
On Deck Capital, Inc.
ONDK
| $3.02M | ﹤0.01% |
387,111
-69,123
| -15% | -$530K |
|
3102
CALL
Canadian Solar
CSIQ
$1.05B
| $3.02M | ﹤0.01% |
156,400
+62,900
| +67% | +$1.29M |
|
3103
Northwest Natural Holdings
NWN
$2.06B
| $3.01M | ﹤0.01% |
55,957
-5,732
| -9% | -$295K |
|
3104
Caesarstone
CSTE
$75.4M
| $3.01M | ﹤0.01% |
87,569
+41,743
| +91% | +$1.49M |
|
|
JPEP
3105
DELISTED
JP Energy Partners LP
JPEP
| $3M | ﹤0.01% |
559,283
-952,300
| -63% | -$4.31M |
|
3106
Sanmina
SANM
$10.4B
| $3M | ﹤0.01% |
128,192
+3,349
| +3% | +$67.3K |
|
3107
PENN Entertainment
PENN
$2.67B
| $3M | ﹤0.01% |
179,448
+88,397
| +97% | +$1.27M |
|
|
MAGN
3108
Magnera Corp
MAGN
$489M
| $2.99M | ﹤0.01% |
11,101
+7,510
| +209% | +$1.7M |
|
3109
CALL
Lexicon Pharmaceuticals
LXRX
$1.03B
| $2.99M | ﹤0.01% |
250,000
-90,000
| -26% | -$944K |
|
|
3110
PUT
Lexicon Pharmaceuticals
LXRX
$1.03B
| $2.99M | ﹤0.01% |
250,000
-90,000
| -26% | -$944K |
|
3111
PUT
Sturm, Ruger & Co
RGR
$616M
| $2.99M | ﹤0.01% |
43,700
+26,800
| +159% | +$1.75M |
|
3112
PUT
Banco Bradesco
BBD
$39.4B
| $2.98M | ﹤0.01% |
851,837
+690,228
| +427% | +$1.8M |
|
|
AMED
3113
DELISTED
Amedisys
AMED
| $2.98M | ﹤0.01% |
61,584
+21,535
| +54% | +$831K |
|
3114
New York Times
NYT
$12.2B
| $2.98M | ﹤0.01% |
238,940
-17,071
| -7% | -$216K |
|
|
MBLY
3115
CALL
DELISTED
Mobileye N.V.
MBLY
| $2.97M | ﹤0.01% |
79,700
+18,000
| +29% | +$573K |
|
3116
Cavco Industries
CVCO
$4.21B
| $2.97M | ﹤0.01% |
31,759
-28,280
| -47% | -$2.33M |
|
3117
PUT
Prudential Financial
PRU
$42.7B
| $2.97M | ﹤0.01% |
41,100
-71,200
| -63% | -$4.96M |
|
|
LNCE
3118
DELISTED
Snyders-Lance, Inc.
LNCE
| $2.97M | ﹤0.01% |
94,220
+35,562
| +61% | +$1.14M |
|
3119
CALL
Sherwin-Williams
SHW
$86B
| $2.96M | ﹤0.01% |
31,200
-4,200
| -12% | -$368K |
|
|
MRLN
3120
DELISTED
Marlin Business Services Corp
MRLN
| $2.96M | ﹤0.01% |
206,665
| – | – |
|
|
ISCA
3121
DELISTED
International Speedway Corp
ISCA
| $2.95M | ﹤0.01% |
79,953
+23,183
| +41% | +$790K |
|
3122
CALL
Consolidated Edison
ED
$39.8B
| $2.94M | ﹤0.01% |
38,400
+12,400
| +48% | +$880K |
|
|
INSY
3123
PUT
DELISTED
Insys Therapeutics, Inc.
INSY
| $2.94M | ﹤0.01% |
183,800
+89,000
| +94% | +$1.69M |
|
3124
Heron Therapeutics
HRTX
$96.8M
| $2.94M | ﹤0.01% |
154,671
+107,754
| +230% | +$2.13M |
|
|
CKEC
3125
DELISTED
Carmike Cinemas Inc
CKEC
| $2.93M | ﹤0.01% |
97,648
-744,569
| -88% | -$18.1M |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.